677
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Emerging therapies for rheumatoid arthritis

, MD PhD & , MD PhD
Pages 231-244 | Published online: 02 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Barry J Sheane & Vinod Chandran. (2014) Investigational drugs for treating psoriatic arthritis. Expert Opinion on Investigational Drugs 23:7, pages 1001-1016.
Read now

Articles from other publishers (10)

Tong Zhu, Selina Moy, Udaya Valluri, Ying Cao, Wenhui Zhang, Taiji Sawamoto, Vishala Chindalore & Bola Akinlade. (2020) Investigation of Potential Drug–Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis. Clinical Drug Investigation 40:9, pages 827-838.
Crossref
Tateiwa, Yoshikawa & Kaito. (2019) Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review. Cells 8:8, pages 818.
Crossref
Chieyeon Chough, Misuk Joung, Sunmin Lee, Jaemin Lee, Jong Hoon Kim & B. Moon Kim. (2018) Development of selective inhibitors for the treatment of rheumatoid arthritis: (R)-3-(3-(Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)pyrrolidin-1-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor. Bioorganic & Medicinal Chemistry 26:8, pages 1495-1510.
Crossref
Chieyeon Chough, Sunmin Lee, Misuk Joung, Jaemin Lee, Jong Hoon Kim & B. Moon Kim. (2018) Design, synthesis and evaluation of ( R )-3-(7-(methyl(7 H -pyrrolo[2,3- d ]pyrimidin-4-yl)amino)-5-azaspiro[2.4]heptan-5-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor . MedChemComm 9:3, pages 477-489.
Crossref
Jingchao Hao, Xiaodong Wu, Sarra Setrerrahmane, Kun Qian, Yueying Hou, Liting Yu, Chenyu Lin, Qianqian Wu & Hanmei Xu. (2017) Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis. International Journal of Molecular Sciences 18:7, pages 1538.
Crossref
Joel M. Kremer, Paul Emery, Heidi S. Camp, Alan Friedman, Li Wang, Ahmed A. Othman, Nasser Khan, Aileen L. Pangan, Steven Jungerwirth & Edward C. Keystone. (2016) A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy. Arthritis & Rheumatology 68:12, pages 2867-2877.
Crossref
Ying Jun Cao, Taiji Sawamoto, Udaya Valluri, Kathy Cho, Michaelene Lewand, Suzanne Swan, Kenneth Lasseter, Mark Matson, John HolmanJrJr, James Keirns & Tong Zhu. (2016) Pharmacokinetics, Pharmacodynamics, and Safety of ASP015K (Peficitinib), a New Janus Kinase Inhibitor, in Healthy Subjects. Clinical Pharmacology in Drug Development 5:6, pages 435-449.
Crossref
F Ahmad, T Murata, K Shimizu, E Degerman, D Maurice & V Manganiello. (2014) Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets. Oral Diseases 21:1.
Crossref
Heather A. Arnett & Joanne L. Viney. (2014) Immune modulation by butyrophilins. Nature Reviews Immunology 14:8, pages 559-569.
Crossref
Jianlu Wei, Brendon Richbourgh, Tanghong Jia & Chuanju Liu. (2014) ADAMTS-12: A Multifaced Metalloproteinase in Arthritis and Inflammation. Mediators of Inflammation 2014, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.